Patents by Inventor Martin Procter

Martin Procter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperidine GPCR Agonists
    Publication number: 20100048631
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
    Type: Application
    Filed: January 4, 2008
    Publication date: February 25, 2010
    Inventors: Matthew Colin Thor Fyfe, John Keily, Martin Procter, David French Stonehouse, Simon Andrew Swain
  • HETEROCYCLIC DERIVATIVES AS GPCR RECEPTOR AGONISTS
    Publication number: 20090281060
    Abstract: Compounds of Formula (I), R1-A-V—B—R2; or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.
    Type: Application
    Filed: December 23, 2004
    Publication date: November 12, 2009
    Applicant: PROSIDION LIMITED
    Inventors: Matthew Fyfe, John King-Underwood, Lisa Sarah Bertram (Gardner), Gerard Hugh Thomas, Martin Procter, Chrystelle Rasamison, Karen Schofield
  • TRI(CYCLO) SUBSTITUTED AMIDE COMPOUNDS
    Publication number: 20070281946
    Abstract: Compounds of Formula (I): or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.
    Type: Application
    Filed: April 16, 2007
    Publication date: December 6, 2007
    Inventors: Matthew Fyfe, Lisa Gardner, Maseo Nawano, Martin Procter, Chrystelle Rasamison, Karen Schofield, Vilasben Shah, Kosuke Yasuda
  • PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSPHORYLASE
    Publication number: 20070244090
    Abstract: Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants.
    Type: Application
    Filed: May 20, 2004
    Publication date: October 18, 2007
    Inventors: Stuart Bradley, Thomas Krulle, Peter Murray, Martin Procter, Robert Rowley, Colin Sambrook Smith, Gerard Thomas
  • RESORCINOL DERIVATIVES
    Publication number: 20070122367
    Abstract: The present invention relates to certain resorcinol derivatives and their use as skin lightening agents.
    Type: Application
    Filed: November 21, 2006
    Publication date: May 31, 2007
    Applicants: PFIZER INC., PFIZER PRODUCTS INC.
    Inventors: Stuart Bradley, Eric Collington, Matthew Fyfe, Martin Procter, Colin Sambrook Smith
  • Resorcinol derivatives
    Publication number: 20050282899
    Abstract: The present invention relates to certain resorcinol derivatives and their use as skin lightening agents.
    Type: Application
    Filed: December 2, 2004
    Publication date: December 22, 2005
    Inventors: Stuart Bradley, Eric Collington, Matthew Fyfe, Martin Procter, Colin Sambrook Smith
  • Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
    Publication number: 20050261272
    Abstract: Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants.
    Type: Application
    Filed: May 20, 2004
    Publication date: November 24, 2005
    Inventors: Stuart Bradley, Thomas Krulle, Peter Murray, Martin Procter, Robert Rowley, Colin Sambrook Smith, Gerard Thomas
  • Benzyl sulfonamide derivatives
    Publication number: 20050137228
    Abstract: The present invention is directed to a new class of 6-benzylsulfonamido-quinoline/chromene derivatives, to their use as androgen antagonists, and to formulations containing these androgen antagonists.
    Type: Application
    Filed: April 14, 2004
    Publication date: June 23, 2005
    Inventors: Daniel Du, Martin Procter, Matthew Thor Fyfe, Vilasben Shah, Geoffrey Williams, Karen Schofield
  • Benzyl urea and thiourea derivatives
    Publication number: 20050107427
    Abstract: The present invention is directed to a new class of 6-benzyl urea/thiourea-quinolin-2-one derivatives and 2-oxo-6-benzylurea/thiourea-chromene derivatives. These compound are androgen antagonists and are useful in the treatment of alopecia, acne and other conditions associated with inappropriate activation of the androgen receptor.
    Type: Application
    Filed: February 10, 2004
    Publication date: May 19, 2005
    Inventors: Daniel Du, Martin Procter, Matthew Fyfe, Vilasben Shah, Geoffrey Williams, Karen Schofield
  • Androgen receptor antagonists
    Publication number: 20050085466
    Abstract: The present invention is directed to a new class of 6-sulfonamido-quinolin-2-one and 6-sulfonamido-2-oxo-chromene derivatives to their use as androgen antagonists, and to relieve conditions associated with inappropriate activation of the androgen receptor.
    Type: Application
    Filed: January 15, 2004
    Publication date: April 21, 2005
    Inventors: Daniel Du, Matthew Fyfe, Martin Procter, Karen Schofield, Vilasben Shah, Geoffrey Williams
  • Androgen receptor antagonists
    Publication number: 20050085467
    Abstract: The present invention is directed to a new class of 6-sulfonamido-quinolin-2-one and 6-sulfonamido-2-oxo-chromene derivatives to their use as androgen antagonists, and to relieve conditions associated with inappropriate activation of the androgen receptor.
    Type: Application
    Filed: January 15, 2004
    Publication date: April 21, 2005
    Inventors: Daniel Du, Matthew Thor Fyfe, Martin Procter, Karen Schofield, Vilasben Shah, Geoffrey Williams
  • Sulfonamide derivatives
    Publication number: 20050004367
    Abstract: The present invention is directed to a new class of 6-sulfonamide quinoline and chromene derivative and to their use as androgen antagonists.
    Type: Application
    Filed: March 16, 2004
    Publication date: January 6, 2005
    Inventors: Daniel Du, Matthew Fyfe, Martin Procter, Karen Schofield, Vilasben Shah, Geoffrey Williams